Atea Pharmaceuticals (AVIR) Net Income: 2019-2024
Historic Net Income for Atea Pharmaceuticals (AVIR) over the last 6 years, with Dec 2024 value amounting to -$168.4 million.
- Atea Pharmaceuticals' Net Income fell 129.40% to -$34.4 million in Q4 2022 from the same period last year, while for Dec 2022 it was -$115.9 million, marking a year-over-year decrease of 195.64%. This contributed to the annual value of -$168.4 million for FY2024, which is 23.85% down from last year.
- Per Atea Pharmaceuticals' latest filing, its Net Income stood at -$168.4 million for FY2024, which was down 23.85% from -$136.0 million recorded in FY2023.
- In the past 5 years, Atea Pharmaceuticals' Net Income registered a high of $121.2 million during FY2021, and its lowest value of -$168.4 million during FY2024.
- In the last 3 years, Atea Pharmaceuticals' Net Income had a median value of -$136.0 million in 2023 and averaged -$140.1 million.
- Per our database at Business Quant, Atea Pharmaceuticals' Net Income surged by 1,207.06% in 2021 and then crashed by 195.64% in 2022.
- Over the past 5 years, Atea Pharmaceuticals' Net Income (Yearly) stood at -$10.9 million in 2020, then spiked by 1,207.06% to $121.2 million in 2021, then tumbled by 195.64% to -$115.9 million in 2022, then decreased by 17.30% to -$136.0 million in 2023, then fell by 23.85% to -$168.4 million in 2024.